ALERT AFFIDAVIT OF LTC. THERESA LONG M.D. IN SUPPORT OF A MOTION FOR A PRELIMINARY INJUNCTION ORDER

[goosebeans]

Buick Electra posted this in the Q thread but I think it deserves a stand alone thread.

This army flight surgeon recommends that "all injected pilots and flight crews are grounded for their risk of cardiac arrest in flight, while carrying personnel or munitions." 3 pulmonary embolisms in ICU within 48 hours of jab at Ft. Hood. It's just horrifying. The bodies of some of our fittest young soldiers just falling apart after taking the vax.

Please take the time to read the whole thing. The beginning may be a bit dry as she is listing all of her many qualifications. I've worked with army flight surgeons. I know how much care is taken to ensure that our military pilots and crews are in top physical condition in order to do their jobs. Just can't believe that this is being swept under the rug and that this doctor has to put her career on the line to get the message out.

I'm not used to posting articles so if someone can bring it over for me I would much appreciate it.

AFFIDAVIT OF LTC. THERESA LONG M.D. IN SUPPORT OF A MOTION FOR A PRELIMINARY INJUNCTION ORDER – Deep Capture

 

[Hognutz]

Victory in Jesus.!,,,

 

[EMICT]

AFFIDAVIT OF LTC. THERESA LONG M.D. IN SUPPORT OF A MOTION FOR A PRELIMINARY INJUNCTION ORDER

SEPTEMBER 24, 2021

I, Lieutenant Colonel Theresa Long, MD, MPH, FS being duly sworn, depose and state as follows:

1. I make this affidavit, as a whistle blower under the Military Whistleblower Protection Act, Title 10 U.S.C. § 1034, in support of the above referenced MOTION as expert testimony in support thereof.

2. The expert opinions expressed here are my own and arrived at from my persons, professional and educational experiences taken in context, where appropriate, by scientific data, publications, treatises, opinions, documents, reports and other information relevant to the subject matter and are not necessarily those of the Army or Department of Defense.

Experience & Credentials

3. I am competent to testify to the facts and matters set forth herein. A true and accurate copy of my curriculum vitae is attached hereto as Exhibit A.

4. After receiving a bachelor’s degree from the University of Texas Austin, completed my medical degree from the University of Texas Health Science Center at Houston Medical School in 2008. I served as a Field Surgeon for ten years and went on to complete a residency in Aerospace and Occupational Medicine at the United States Army School of Aviation Medicine, Fort Rucker, AL. I hold a Master’s in Public Health, and I have been trained by the Combat Readiness Center at Ft. Rucker as an Aviation Safety Officer. Additionally, I have trained in the Medical Management of Chemical and Biological Causalities at Fort Detrick and USAMIIRD.

5. I am board certified in flight Aerospace Medicine and board eligible in Occupational Medicine.

6. I am currently serving as the Brigade Surgeon for the 1st Aviation Brigade Ft. Rucker, Alabama and am responsible for certifying the health, mental and physical ability, and readiness for all nearly 4,000 individuals on flight status on this post.

7. My appended curriculum vitae further demonstrates my academic and scientific achievements by me over the past thirteen years.

8. Prior to the outset of the pandemic, I received specialized military training from Infectious Disease doctors from the Army, Navy and Air Force on emerging infectious disease threats, FEMA training, Emergency preparedness training, Medical effects of Ionizing Radiation, OSHA, Aerospace Toxicology, Epidemiology, Biostatistics, medical research and disaster planning. More recently I have functioned as a medical and scientific advisor to an Aviation training Brigade seeking to identify risk mitigation strategies, and bio statistical analysis of SARS- Cov-2 (“Covid 19”) infections in both vaccinated and unvaccinated Soldiers. In so doing, I have identified, diagnosed and treated Covid 19 pathogenic infections. I have observed vaccine adverse events following the administration of EUA vaccines, and followed the success of Soldiers who obtained various Covid 19 therapies outside the military. The majority of the service members within the DOD population are young and in good physical condition. Military aviators are a subset of the military population that has to meet the most stringent medical standards to be on flight status. The population of student pilots I take care of are primarily in their 20s-30s, males and in excellent physical condition. The risk of serious illness or death in this population from SARs-CoV-2 is minimal, with a survival rate of 99.997%.

9. In observing, studying and analyzing all the available data, information, samples, experiences, histories and results of these treatments and inoculations provided, I have formulated a professional opinion, which requires me to report those findings to superiors in the chain of command and colleagues in the military. I have done so with mixed results in terms of acceptance, rejection and threats of punishment for so sharing.

10. The application of risk management is critical to the safety and success in both medicine and aviation. Aerospace Medicine is a specialty devoted to safety of flight by the aeromedical dispositioning and treatment of flight crew members, as accomplished by the consistent and careful application of risk mitigation and management strategies. ATP 5-19, 1-3. Risk Management (RM)1 outlines a disciplined approach to express a risk level in terms readily understood at all echelons.
1 adminpubs.tradoc.army.mil/regulations/TR385-2withChange1.docx 4
Case 1:21-cv-02228-RM-STV Document 17 Filed 09/24/21 USDC Colorado Page 7 of 269

11. 1-6. States, “A risk decision is a commander, leader, or individual’s determination to accept or not accept. The risk(s) associated with an action he or she will take or will direct others to take. RM is only effective when specific information about hazards and risks is passed to the appropriate level of command for a risk decision. Subordinates must pass specific risk information up the chain of command.”

12. “When the specific information about hazards and risks is passed to the appropriate level of command for a risk decision. Subordinates must pass specific risk information up the chain of command. Conversely, the higher command must provide subordinates making risk decisions or implementing controls with the established risk tolerance—the level of risk the responsible commander is willing to accept. RM application must be inclusive; those executing an operation and those directing it participate in an integrated process”.

13. 1-7. States, “In the context of RM, a control is an action taken to eliminate a hazard or to reduce its risk. Commanders establish local policies and regulations if appropriate”.

14. The five steps of Risk management include; 1. Identify the hazards, 2. Assess the hazards, 3. Develop controls and make risk decisions, 4. Implement controls, 5. Supervise and evaluate.

15. It is therefore my responsibility and that of every leaders to apply the steps of risk management to the current pandemic and countermeasures used. The CDC and the FDA are civilian agencies that do not have the mission of National Defense that the DOD has. Guidance and recommendations made by these civilian agencies must be filtered through strategic perspective of national defense and the potential risks recommendations may have on the health of the entire fighting force. Ensuring that the health of the fighting force is not compromised is a strategic imperative, for which every military physician is responsible to of the entire fighting force. Ensuring that the health of the fighting force is not compromised is a strategic imperative, for which every military physician is responsible to ensure.

16. Step 1: Identify the hazards: As defined by FM 1-02.1 Operational Terms, pg. 1- 48, hazard is a condition with the potential to cause injury, illness, or death of personnel; damage to or loss of equipment or property; or mission degradation.

17. Step 2: Assess the Hazards: There are numerous therapeutic agents that have been proven to significantly reduce infection and therefore provide protection from the harmful effects of SARs-CoV-2.

18. Literature has demonstrated that natural immunity is durable, completed, and superior to vaccination immunity to SARs-CoV-2. mRNA vaccines produced by Pfizer and Moderna both have been linked to myocarditis, especially in young males between 16-24 years old,2 The majority of young new Army aviators are in their early twenties. We know there is a risk of myocarditis with each mRNA vaccination. We additionally now know that vaccination does not necessarily prevent infection or transmission of SARs-CoV-2Therefore individuals fully vaccinated with mRNA vaccines have at least two independent risk factors for myocarditis after vaccination. Additional boaster shots add more risk. It is impossible to perform a risk/benefit analysis on the use of mRNA as counter measures to SARs-CoV-2 without further data… Use of mRNA vaccines in our fighting force, presents a risk of undetermined magnitude, in a population in which less than 20 active-duty personnel out of 1.4 million, died of the underlying SARs- CoV-2.

19. Aircrew Training Program (ATP) 5-19, 1-8. Accept No Unnecessary Risk, states, “An unnecessary risk is any risk that, if taken, will not contribute meaningfully to mission accomplishment or will needlessly endanger lives or resources. Army leaders accept only a level of risk in which the potential benefit outweighs the potential loss.

20. Research shows that most individuals with myocarditis do not have any symptoms. Complications of myocarditis include dilated cardiomyopathy, arrhythmias, sudden cardiac death and carries a mortality rate of 20% at one year and 50% at 5 years. According to the National Center for Biotechnology Information, U.S. National Library of Medicine, “despite optimal medical management, overall mortality has not changed in the last 30 years”.

21. Step 3: Develop controls and make risk decisions: Because vaccination with mRNA increase the risk of myocarditis, a comprehensive screening program should be implemented immediately to identify individuals who have been affected and attempt to mitigate immediate risks and long-term disability.

22. Step 4: Implement Controls: Send out clear guidance to all DOD healthcare professionals on risks of-vaccination myocarditis. Compulsory SARs-CoV-2 mRNA vaccination program should be immediately suspended until research can be done to determine the true magnitude of risk of myocarditis in individuals who have been vaccinated. We must evaluate and immediately implement alternatives to mRNA vaccines, to include Ivermectin (FDA approved 1996), Remdesivir (FDA approved 2020), Hydroxychloroquine (FDA approved 1955), Regeneron (FDA EU approved 2020). Review VAERS data for deaths from COVID for age-matched data and data from active duty COVID deaths within the DOD to perform a risk/benefit analysis.

23. Step 5: Supervise and evaluate: We must establish a screening program to identify those at increased risk of myocarditis, i.e. those that have, received mRNA vaccinations with Comirnaty, BioNTech or Moderna, or have any of the following symptoms chest pain, shortness of breath or palpitations They should have screening tested performed in accordance with the CDC recommendations prior to return to flight duties. Per the CDC guidelines the initial evaluation of individuals identified according to the above criteria include; ECG, troponion level, inflammatory markers such as the C-reactive protein and erythrocyte sedimentation rate. It should be noted that the gold standard for diagnosis of myocarditis is end myocardial biopsy (EMB).

24. Given that the labels for Comirnaty and BioNtech clearly state that the vaccination should not be given to individuals that are allergic to ingredients. I have noted that one of the primary ingredients of the Lipid Nanoparticle delivery system is “ALC 1035” (two attachments, parts highlighted) in the Pfizer shots. The forth attachment is the toxicity report on ALC-1035, which comprises between 30-50% of the total ingredients.3 The Safety Data Sheet, (attached as Exhibit B) for this primary ingredient states that it is Category 2 under the OSHA HCS regulations (21 CFR 1910) and includes several concerning warnings, including but not limited to:

1. Seek medical attention if it comes into contact with your skin;
2. If inhaled and If breathing is difficult, give cardiopulmonary resuscitation
3. Evacuate if there is an environmental spill
4. the chemical, physical, and toxicological properties have not been completely investigated
5. Caution: Product has not been fully validated for medical applications. For research use only

25. Other journals and scientific papers also denote that this particular ingredient has never been used in humans before.4 To be abundantly clear, one of the listed primary ingredients of these injectables is Polyethylene glycol (“PEG”) which is a derivative of ethylene oxide. Polyethylene Glycol is the active ingredient in antifreeze. While it is hard to believe this is a key ingredient in these vaccines, it would explain the increased cardiovascular risk to users of the BioNTech or Comirnaty shots. I cannot discern what form of alchemy Pfizer and the FDA have discovered that would make antifreeze into a healthful cure to the human body. Others seem to agree my point per recent scientific studies that caused a group of 57 doctors and scientists to call for an immediate halt to the vaccination program.5 In short, this antifreeze ingredient is being studied for the first time in human injectables. According to the VAERS data, which admittedly underreports by as much as 100 times the actual SAE’s, there are well more than 600,000 documented Serious Adverse Events (ones requiring medical attention) alone and more than 13,000 fatalities directly linked to this particular vaccine. I cannot understand how this vaccine remains on the list of available options to treat Covid, when there are so many other non-deadly or injurious options available.

26. As such, I believe it is reasonable to conclude that many humans are allergic to these dangerous and deadly toxins and therefore should not take vaccinations with either Comirnaty or BioNtech. Again, I have identified an agent that possess a significant hazard to Soldiers, which would fall under DA Pam 385-61 Toxic Safety Standards cited in 2-11.

27. My assessment is that ALC 0315 is a known toxin with little study, specifically restricted to “research only“ and effectively has no prior use history, with the SDS designation of (GHS02), listed as H315 and H319, in other words, hazardous if inhaled, ingested or in contact with skin and a health hazard with the designation (P313). A review of the SDS outlines that it is not for human or veterinary use,

28. I have not taken significant time to delineate the risks of other Covid 19 Vaccines other than the Safety Data Sheet of Moderna’s key ingredient, SM-102 (attached as Exhibit C). Suffice it to say that SM-102 is significantly more dangerous than the Pfizer ALC 3015 and it appears that the DOD is not actively acquiring or distributing this IND/EUA. If the DOD were to undertake use of the Moderna vaccine, one can expect a much higher Serious Adverse Event and fatality rate given that SM-102 carries an express warning “Skull and Crossbones” characterized under the GHS06 and GHS08. In other words, this Moderna ingredient is deadly.

29. Given that these Covid 19 Vaccines were both Investigational New Drugs and Emergency Use Authorization vaccines, I have taken considerable time to understand potential risks, hazards and dangers these and any new drug or Investigational New Drug will may have on the health, safety and operational readiness or ability of pilots under my care and at this post. I have sought to research military records and track systems for recording events and Serious Adverse Events and fatalities associated with vaccines, new vaccines and Emergency Use, investigational vaccines in computer data systems recommended by the General Accounting Office in 2002 and ordered to be developed and implemented by the Secretary of Defense in 2003.

30. A weekly MEDSITREP report fails to report the CDC data from VAERS or internal data regarding vaccine adverse events. Despite recommendation made by the Government Accountability Office in the GAO’s survey of Guard and Reserve Pilots and Aircrew GAO-02-445, published Sep 20,2002, in which it was recommended that the Secretary of Defense should direct the establishment of an active surveillance program (unlike the passive VAERS) to identify and monitor adverse events, was not implemented. I have been unable to locate, access or asses any data, data base or internal system to track, store, evaluate or research the effects of vaccines on our military members or pilots.

31. I have also reviewed scientific data and peer reviewed studies that discuss, analyze results and conclude that natural immunity is at least as good if not far superior to any Covid Vaccine available at this time. I have also reviewed Dr. Peter McCullough’s sworn affidavit in support of and in relation to the Complaint filed in this case and have reviewed its supporting data. An additional peer-reviewed study not referenced in Dr. McCullough’s materials also supports the same conclusions drawn and reports that natural immunity provides a 13 fold better protection against Covid 19 infections than any currently available Covid 19 Vaccine6. More recently, in a meeting of the FDA Advisory Committee on September 17 of this year, fourteen of seventeen members voted against the authorization of any Covid booster vaccines in the juvenile age group having noted that the vaccine program has breached the defining test under the EUA statute as to whether the experimental treatment benefits outweigh the risks; in fact, they found the shots are far more dangerous than helpful in this age group and some voiced concerns that this would apply generally to all age groups.7

32. I am also aware of the Secretary of Defense Austin’s order in relation to Covid Vaccine mandates made this week. In an information paper, it was stated that, “Unit personnel should use only as much force as necessary to assist medical personnel with immunizations.” The use of force to administer a medical treatment or therapy against the will of a mentally competent individual constitutes medical battery and universally violates medical ethics. Currently, I am not aware of the Comirnaty available within the DOD. Emergency Use Authorized vaccines, despite the attempt to characterize some of them as approved despite such approved versions not being available and regardless of a military member’s prior immunity to Covid 19; even where it may be demonstrated with a recent antibody test.

33. Finally, I have reviewed a recent study entitled “US COVID-19 Vaccines Proven to Cause More Harm than Good Based on Pivotal Clinical Trial Data Analyzed Using the Proper Scientific Endpoint, All Cause Severe Morbidity,” by J. Bart Classen, MD and published in Trends in Internal Medicine; August 25, 2021. Attached as Exhibit D.

34. I have also seen policies, memoranda and guidance as it relates to exemptions for vaccinations as fully detailed in Army Regulation 40-562, which purport to eliminate any exemption for prior immunity by our military personnel.

 

[EMICT]

AFFIDAVIT OF LTC. THERESA LONG (Part 2)

Opinion

35. I have reviewed the Motion for a Preliminary Injunction which discusses the issue
of prior immunity benefits outweighing the risks of using experimental Covid 19
Vaccines, together with proposed exhibits and materials cited therein. In opinion on this subject matter, I am also drawing my own conclusions that will be put into practice in my current role as an Army flight surgeon knowing full well the horrific repercussions this decision may befall me in terms of my career, my relationships and life as an Army doctor.

36. I personally observed the most physically fit female Soldier I have seen in over 20 years in the Army, go from Colligate level athlete training for Ranger School, to being physically debilitated with cardiac problems, newly diagnosed pituitary brain tumor, thyroid dysfunction within weeks of getting vaccinated. Several military physicians have shared with me their firsthand experience with a significant increase in the number of young Soldiers with migraines, menstrual irregularities, cancer, suspected myocarditis and reporting cardiac symptoms after vaccination. Numerous Soldiers and DOD civilians have told me of how they were sick, bed-ridden, debilitated, and unable to work for days to weeks after vaccination. I have also recently reviewed three flight crew members’ medical records, all of which presented with both significant and aggressive systemic health issues. Today I received word of one fatality and two ICU cases on Fort Hood; the deceased was an Army pilot who could have been flying at the time. All three pulmonary embolism events happened within 48 hours of their vaccination. I cannot attribute this result to anything other than the Covid 19 vaccines as the source of these events.

37. Each person was in top physical condition before the inoculation and each suffered the event within 2 days post vaccination. Correlation by itself does not equal causation, however, significant causal patterns do exist that raise correlation into a probable cause; and the burden to prove otherwise falls on the authorities such as the CDC, FDA, and pharmaceutical manufacturers. I find the illnesses, injuries and fatalities observed to be the proximate and causal effect of the Covid 19 vaccinations.

38. I can report of knowing over fifteen military physicians and healthcare providers who have shared experiences of having their safety concerns ignored and being ostracized for expressing or reporting safety concerns as they relate to COVID vaccinations. The politicization of SARs-CoV-2, treatments and vaccination strategies have completely compromised long-standing safety mechanisms, open and honest dialogue, and the trust of our service members in their health system and healthcare providers.

39. The subject matter of this Motion for a Preliminary Injunction and its devastating effects on members of the military compel me to conclude and conduct accordingly as follows:

1. a) None of the ordered Emergency Use Covid 19 vaccines can or will provide better immunity than an infection-recovered person;
2. b) All three of the EUA Covid 19 vaccines (Comirnaty is not available), in the age group and fitness level of my patients, are more risky, harmful and dangerous than having no vaccine at all, whether a person is Covid recovered or facing a Covid 19 infection;
3. c) Direct evidence exists and suggests that all persons who have received a Covid 19 Vaccine are damaged in their cardiovascular system in an irreparable and irrevocable manner;
4. d) Due to the Spike protein production that is engineered into the user’s genome, each such recipient of the Covid 19 Vaccines already has micro clots in their cardiovascular system that present a danger to their health and safety;
5. e) That such micro clots over time will become bigger clots by the very nature of the shape and composition of the Spike proteins being produced and said proteins are found throughout the user’s body, including the brain;

1. f) That at the initial stage of this damage the micro clots can only be discovered by a biopsy or Magnetic Resonance Image (“MRI”) scan;
2. g) That due to the fact that there is no functional myocardial screening currently being conducted, it is my professional opinion that substantial foreseen risks currently exist, which require proper screening of all flight crews.
3. h) That, by virtue of their occupations, said flight crews present extraordinary risks to themselves and others given the equipment they operate, munitions carried thereon and areas of operation in close proximity to populated areas.
4. i) That, without any current screening procedures in place, including any Aero Message (flight surgeon notice) relating to this demonstrable and identifiable risk, I must and will therefore ground all active flight personnel who received the vaccinations until such time as the causation of these serious systemic health risks can be more fully and adequately assessed.
5. j) That, based on the DOD’s own protocols and studies, the only two valuable methodologies to adequately assess this risk are through MRI imaging or cardio biopsy which must be carried-out.
6. k) That, in accordance with the foregoing, I hereby recommend to the Secretary of Defense that all pilots, crew and flight personnel in the military service who required hospitalization from injection or received any Covid 19 vaccination be grounded similarly for further dispositive assessment.
7. l) That this Court should grant an immediate injunction to stop the further harm to all military personnel to protect the health and safety of our active duty, reservists and National Guard troops.

40. I am competent to opine on the medical and flight readiness aspects of these allegations based upon my above-referenced education and professional medical, aviation and military experience and the basis of my opinions are formed as a result of my education, practice, training and experience.

41 As an Aerospace Medicine Specialist, and flight surgeon responsible for the lives of our Army pilots, I confirm and attest to the accuracy and truthfulness of my foregoing statements, analysis and attachments or references hereto:
_______________/S/__________________ LTC Theresa Long, MD, MPH, FS

 

[bw]

They would really rather not hear this from one of their own.

 

[goosebeans]

This passage is what really jumped out at me:

36. I personally observed the most physically fit female Soldier I have seen in over 20 years in the Army, go from Colligate level athlete training for Ranger School, to being physically debilitated with cardiac problems, newly diagnosed pituitary brain tumor, thyroid dysfunction within weeks of getting vaccinated. Several military physicians have shared with me their firsthand experience with a significant increase in the number of young Soldiers with migraines, menstrual irregularities, cancer, suspected myocarditis and reporting cardiac symptoms after vaccination. Numerous Soldiers and DOD civilians have told me of how they were sick, bed-ridden, debilitated, and unable to work for days to weeks after vaccination. I have also recently reviewed three flight crew members’ medical records, all of which presented with both significant and aggressive systemic health issues. Today I received word of one fatality and two ICU cases on Fort Hood; the deceased was an Army pilot who could have been flying at the time. All three pulmonary embolism events happened within 48 hours of their vaccination. I cannot attribute this result to anything other than the Covid 19 vaccines as the source of these events. Each person was in top physical condition before the inoculation and each suffered the event within 2 days post vaccination. Correlation by itself does not equal causation, however, significant causal patterns do exist that raise correlation into a probable cause; and the burden to prove otherwise falls on the authorities such as the CDC, FDA, and pharmaceutical manufacturers. I find the illnesses, injuries and fatalities observed to be the proximate and causal effect of the Covid 19 vaccinations.

 

[vestige]

I'll bet she has a mysterious accident soon.

 

[goosebeans]

AFFIDAVIT OF LTC. THERESA LONG (Part 2)

Opinion

35. I have reviewed the Motion for a Preliminary Injunction which discusses the issue
of prior immunity benefits outweighing the risks of using experimental Covid 19
Vaccines, together with proposed exhibits and materials cited therein. In opinion on this subject matter, I am also drawing my own conclusions that will be put into practice in my current role as an Army flight surgeon knowing full well the horrific repercussions this decision may befall me in terms of my career, my relationships and life as an Army doctor.

36. I personally observed the most physically fit female Soldier I have seen in over 20 years in the Army, go from Colligate level athlete training for Ranger School, to being physically debilitated with cardiac problems, newly diagnosed pituitary brain tumor, thyroid dysfunction within weeks of getting vaccinated. Several military physicians have shared with me their firsthand experience with a significant increase in the number of young Soldiers with migraines, menstrual irregularities, cancer, suspected myocarditis and reporting cardiac symptoms after vaccination. Numerous Soldiers and DOD civilians have told me of how they were sick, bed-ridden, debilitated, and unable to work for days to weeks after vaccination. I have also recently reviewed three flight crew members’ medical records, all of which presented with both significant and aggressive systemic health issues. Today I received word of one fatality and two ICU cases on Fort Hood; the deceased was an Army pilot who could have been flying at the time. All three pulmonary embolism events happened within 48 hours of their vaccination. I cannot attribute this result to anything other than the Covid 19 vaccines as the source of these events.

37. Each person was in top physical condition before the inoculation and each suffered the event within 2 days post vaccination. Correlation by itself does not equal causation, however, significant causal patterns do exist that raise correlation into a probable cause; and the burden to prove otherwise falls on the authorities such as the CDC, FDA, and pharmaceutical manufacturers. I find the illnesses, injuries and fatalities observed to be the proximate and causal effect of the Covid 19 vaccinations.

38. I can report of knowing over fifteen military physicians and healthcare providers who have shared experiences of having their safety concerns ignored and being ostracized for expressing or reporting safety concerns as they relate to COVID vaccinations. The politicization of SARs-CoV-2, treatments and vaccination strategies have completely compromised long-standing safety mechanisms, open and honest dialogue, and the trust of our service members in their health system and healthcare providers.

39. The subject matter of this Motion for a Preliminary Injunction and its devastating effects on members of the military compel me to conclude and conduct accordingly as follows:

1. a) None of the ordered Emergency Use Covid 19 vaccines can or will provide better immunity than an infection-recovered person;
2. b) All three of the EUA Covid 19 vaccines (Comirnaty is not available), in the age group and fitness level of my patients, are more risky, harmful and dangerous than having no vaccine at all, whether a person is Covid recovered or facing a Covid 19 infection;
3. c) Direct evidence exists and suggests that all persons who have received a Covid 19 Vaccine are damaged in their cardiovascular system in an irreparable and irrevocable manner;
4. d) Due to the Spike protein production that is engineered into the user’s genome, each such recipient of the Covid 19 Vaccines already has micro clots in their cardiovascular system that present a danger to their health and safety;
5. e) That such micro clots over time will become bigger clots by the very nature of the shape and composition of the Spike proteins being produced and said proteins are found throughout the user’s body, including the brain;

1. f) That at the initial stage of this damage the micro clots can only be discovered by a biopsy or Magnetic Resonance Image (“MRI”) scan;
2. g) That due to the fact that there is no functional myocardial screening currently being conducted, it is my professional opinion that substantial foreseen risks currently exist, which require proper screening of all flight crews.
3. h) That, by virtue of their occupations, said flight crews present extraordinary risks to themselves and others given the equipment they operate, munitions carried thereon and areas of operation in close proximity to populated areas.
4. i) That, without any current screening procedures in place, including any Aero Message (flight surgeon notice) relating to this demonstrable and identifiable risk, I must and will therefore ground all active flight personnel who received the vaccinations until such time as the causation of these serious systemic health risks can be more fully and adequately assessed.
5. j) That, based on the DOD’s own protocols and studies, the only two valuable methodologies to adequately assess this risk are through MRI imaging or cardio biopsy which must be carried-out.
6. k) That, in accordance with the foregoing, I hereby recommend to the Secretary of Defense that all pilots, crew and flight personnel in the military service who required hospitalization from injection or received any Covid 19 vaccination be grounded similarly for further dispositive assessment.
7. l) That this Court should grant an immediate injunction to stop the further harm to all military personnel to protect the health and safety of our active duty, reservists and National Guard troops.

40. I am competent to opine on the medical and flight readiness aspects of these allegations based upon my above-referenced education and professional medical, aviation and military experience and the basis of my opinions are formed as a result of my education, practice, training and experience.

41 As an Aerospace Medicine Specialist, and flight surgeon responsible for the lives of our Army pilots, I confirm and attest to the accuracy and truthfulness of my foregoing statements, analysis and attachments or references hereto:
_______________/S/__________________ LTC Theresa Long, MD, MPH, FS

Thanks EMICT!

 

[Dozdoats]

Wow.

I entered Federal civil service at Mother Rucker. I know whereof she speaks.

I do not doubt military vaxxxidents will follow if they have not already happened.

 

[PrairieMoon]

WOW!!!! This needs to go viral! I keep telling my co-workers that this is happening. Finally, someone is paying attention.

 

[night driver]

well, she ATTEMPTED to cloak herself in the proper and SPECIFIC protections, we'll see how far that gets her.

If this is the same woman in Aesop's vid, she is HIGHLY effective as a presenter.

Wish her luck and bullet-proof Guardian Angels.

She is far enough up the chain that there are a LOT of folks under her STATUTORY care....

 

[bw]

She may also mysteriously disappear.

 

[Walrus]

I saw that Aesop had posted this on his raconteur blog - glad that you picked it up and posted it here.

 

[OldAndCrazy]

Hope she has a good retirement plan.

 

[SageRock]

May the Holy Spirit guard her with great power!

 

[Countrymouse]

God bless & protect this brave hero!

 

[desertvet2]

We are under attack from within.

After we are sufficiently softened...


From without.

 

[goosebeans]

It really does need to go viral.

The military is a very healthy, physically fit population. At least it was back in the 90 s when I was in. Sick call mostly consisted of colds, back pain ( "1st sgt had us moving wall lockers all day..." ) sprained ankles during the morning run. All normal stuff that comes with hard work and hard training. The only three anomalies that I recall in the four years I was in was a young guy who came in to our MASH unit in Korea complaining of a rash on his back which turned out to be shingles and another guy who came in day after day complaining of dizziness. The doc couldn't find anything wrong with him and finally sent word to his command that he was a malingerer, just trying to get out of work. Then a while later she was besides herself after reading up on Meniere disease and was franticly trying to remember his name and unit to get back in touch with them. ( I don't think we kept records of who came in when ) The other was 20 year old guy in Somalia who came in to our little field clinic/ER with terrible tremors. Couldn't hold himself still. Poor kid he was terrified. I asked him when it started and he said it just came on suddenly. I can still see the concern on our docs face as he examined him and hear his words "You're going home, buddy" he sat down and wrote a letter to the kid's commander because under no circumstances was he to be in possession of a firearm.

All this to say, cardiac events, embolisms and such are not things you see on a regular basis in that environment.

 

[Vegas321]

Wow...

 

[Housecarl]

Merde!.........

 

[Dozdoats]

It's called "the practice of medicine" because it it a lifelong learning experience.

There is a LOT of metal in the air all day (and night) at Rucker.

 

[goosebeans]

I saw that Aesop had posted this on his raconteur blog - glad that you picked it up and posted it here.

Well, it was Buick Electra who posted it over at the Q thread. It just jumped out at me because I'm sick of hearing "well, lots of people have underlying conditions that they don't know about" "well, they were old, it probably had nothing to do with the vaccine" or the one my chemist friend uses as she rolls her eyes at me "they would have died anyway!" It's easy to blow smoke when talking about the general population. Military pilots, not so much!

 

[vestige]

Well, it was Buick Electra who posted it over at the Q thread. It just jumped out at me because I'm sick of hearing "well, lots of people have underlying conditions that they don't know about" "well, they were old, it probably had nothing to do with the vaccine" or the one my chemist friend uses as she rolls her eyes at me "they would have died anyway!" It's easy to blow smoke when talking about the general population. Military pilots, not so much!

I would think the same applied to civilian pilots and all who operate any form of mass transportation.

How about drivers of hazmat vehicles?

 

[niceguy]

Everything she says looks right, except possibly this:

Polyethylene Glycol is the active ingredient in antifreeze.

Apparently a common, or at least not unheard of, error:

Polyethylene Glycol Vs. Ethylene Glycol

Polyethylene glycol and ethylene glycol are very different compounds. In controlled amounts, polyethylene glycol is not harmful if ingested and is an ingredient in laxative medications. Ethylene glycol, by contrast, is very toxic and is best known for its use in antifreeze and deicer solutions.

sciencing.com

I hope this doesn't get used to undermine everything else she says. As Goosebeans notes, she provides valuable case study information.

 

[niceguy]

I would think the same applied to civilian pilots and all who operate any form of mass transportation.

How about drivers of hazmat vehicles?

There were rumors (on Twitter) of BOA having issues with pilots, back much closer to the beginning of the jabbing. But I don't think that anything came of it.

 

[Countrymouse]

Everything she says looks right, except possibly this:



Apparently a common, or at least not unheard of, error:

Polyethylene Glycol Vs. Ethylene Glycol

Polyethylene glycol and ethylene glycol are very different compounds. In controlled amounts, polyethylene glycol is not harmful if ingested and is an ingredient in laxative medications. Ethylene glycol, by contrast, is very toxic and is best known for its use in antifreeze and deicer solutions.

sciencing.com

I hope this doesn't get used to undermine everything else she says. As Goosebeans notes, she provides valuable case study information.

True, but I found FAR more concerning and noticeable THIS statement:

I have noted that one of the primary ingredients of the Lipid Nanoparticle delivery system is “ALC 1035” (two attachments, parts highlighted) in the Pfizer shots. The fourth attachment is the toxicity report on ALC-1035, which comprises between 30-50% of the total ingredients. 3 The Safety Data Sheet, (attached as Exhibit B) for this primary ingredient states that it is Category 2 under the OSHA HCS regulations (21 CFR 1910) and includes several concerning warnings, including but not limited to:

1. Seek medical attention if it comes into contact with your skin;
2. If inhaled and If breathing is difficult, give cardiopulmonary resuscitation
3. Evacuate if there is an environmental spill
4. the chemical, physical, and toxicological properties have not been completely investigated
5. Caution: Product has not been fully validated for medical applications. For research use only

25. Other journals and scientific papers also denote that this particular ingredient has never been used in humans before...

Now I WISH this copy of her statement included her ATTACHMENTS_--because "if" this "ALC-1035" IS PEG (Polyethylene Glycol) and IF it is the SAME Polyethylene Glycol used in laxatives--thenWHY would there be a "TOXICITY REPORT" on "ALC-1035" and WHY would this "TOXIC" substance "comprise between 30-50% of the total ingredients"? If "ALC-1035" IS "Polyethylene Glycol" then WHY is it listed as a Category 2 substance under OSHA regulations, necessitating the above warnings?

OBVIOUSLY, "ALC-1035" MUST be something QUITE DIFFERENT from normal "Polyethylene Glycol".

I've been trying to do a search on "ALC 1035"---came up dry, so tried "ALC 1035 Pfizer" and so far have found "some" concerning things---but all of them seem to indicate that ALC-1035" either IS polyethylene glycol, OR---that there's some missing piece to this puzzle I'm not getting yet. The use of PEG in laxatives and the WARNINGS about it which she cites above don't match---

and this is MORE than just her confusing "Polyethylene Glycol" with "Ethylene Glycol"---look again at her statement:

one of the primary ingredients of the Lipid Nanoparticle delivery system is “ALC 1035” (two attachments, parts highlighted) in the Pfizer shots.

AND

The fourth attachment is the toxicity report on ALC-1035,

For further review, I did find ONE tiny study done in Singpore, about anaphylactic reactions to the Polyethylene Glycol in the Pfizer shots. This is a PDF (link below) and I do note it mentions the "1035" figure as being something related to the Immunoglobulin G (IgG) which is (per Wikipedia) "IgG is the main type of antibody found in blood and extracellular fluid, allowing it to control infection of body tissues. By binding many kinds of pathogens such as viruses, bacteria, and fungi, IgG protects the body from infection."

I copied only the Introduction, Description, and Conclusions of the study (it's 7 pages total if you go to the link)

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine
https://www.mdpi.com › pdf

Case Report
Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine:
Report of 3 Cases of Anaphylaxis Post Pfizer
BNT162b2 Vaccination
Xin Rong Lim 1,* , Bernard Pui Leung 1,2, Carol Yee Leng Ng 3, Justina Wei Lynn Tan 1, Grace Yin Lai Chan 1,
Chien Mei Loh 3, Gwendolyn Li Xuan Tan 3, Valerie Hui Hian Goh 3, Lok To Wong 3, Chong Rui Chua 3,
Sze Chin Tan 1, Samuel Shang Ming Lee 1, Hwee Siew Howe 1, Bernard Yu Hor Thong 1 and Khai Pang Leong 1,3


Citation: Lim, X.R.; Leung, B.P.; Ng,
C.Y.L.; Tan, J.W.L.; Chan, G.Y.L.; Loh,
C.M.; Tan, G.L.X.; Goh, V.H.H.; Wong,
L.T.; Chua, C.R.; et al. Pseudo-
Anaphylactic Reactions to Pfizer
BNT162b2 Vaccine: Report of 3 Cases
of Anaphylaxis Post Pfizer BNT162b2
Vaccination. Vaccines 2021, 9, 974.

https://doi.org/10.3390/

vaccines9090974
Academic Editor: Stefano D’Errico
Received: 5 July 2021
Accepted: 27 August 2021
Published: 31 August 2021

Copyright: © 2021 by the authors.

1 Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng,
Singapore 308433, Singapore; bernard.p.leung@gmail.com (B.P.L.); justina_tan@ttsh.com.sg (J.W.L.T.);
grace_yl_chan@ttsh.com.sg (G.Y.L.C.); sze_chin_tan@ttsh.com.sg (S.C.T.);
samuel_lee@ttsh.com.sg (S.S.M.L.); Howe_hwee_siew@ttsh.com.sg (H.S.H.);
bernard_thong@ttsh.com.sg (B.Y.H.T.); khai_pang_leong@ttsh.com.sg (K.P.L.)
2 Health and Social Sciences, Singapore Institute of Technology, Singapore 138683, Singapore
3 Clinical Immunology Laboratory, Tan Tock Seng Hospital, Singapore 308433, Singapore;
carol_ng@ttsh.com.sg (C.Y.L.N.); chien_mei_loh@ttsh.com.sg (C.M.L.);
Gwendolyn_TAN@ttsh.com.sg (G.L.X.T.); Hui_Hian_Valerie_GOH@ttsh.com.sg (V.H.H.G.);
Lok_To_WONG@ttsh.com.sg (L.T.W.); Chong_Rui_CHUA@ttsh.com.sg (C.R.C.)
* Correspondence: xin_rong_lim@ttsh.com.sg; Tel.: +(65)-6357-7822; Fax: +(65)-6357-2686

Abstract: Anaphylactic reactions were observed after Singapore’s national coronavirus disease 2019 (COVID-19) vaccination programme started in December 2020. We report the clinical and laboratory features of three patients in our institution who developed anaphylactic reactions after receiving the Pifzer BNT162b2 vaccine. IgM and IgG antibodies, but not IgE antibodies to the Pfizer BNT162b2 vaccine, were detected in all subjects. Similarly, mild to high elevated levels of anti-polyethylene glycol (PEG) IgG (1035–19709 U/mL, vs. vaccine-naive < 265 U/mL, vaccine-tolerant < 785 U/mL) and IgM (1682–5310 U/mL, vs. vaccine-naive < 1011 U/mL, vaccine-tolerant < 1007 U/mL) were detected in two out of three patients via commercial ELISA. High levels of serum anaphylatoxin C3a
(79.0 6.3 g/mL, mean SD, vs. normal < 10 g/mL) were observed in all three patients during
the acute phase of the reaction, while tryptase levels, a marker of mast cell activation, were not
elevated. Finally, one patient with the highest levels of anti-PEG IgG, IgM, and anti-Pfizer BNT162b2
IgG and IgM exhibited an enhanced Th2 cytokine serum profile during an acute reaction, with high
levels of IL-4 (45.7 pg/mL, vs. vaccine-naive/tolerant < 2.30 pg/mL), IL-33 (86.4 pg/mL, vs. vaccinenaive/
tolerant < 5.51 pg/mL) and IL-10 (22.9 pg/mL, vs. vaccine-naive/tolerant < 12.49 pg/mL)
diminishing over time following corticosteroid treatment. Taken together, we propose these cases
of anaphylaxis described are driven by a complement activation-related pseudoallergy (CAPRA),
rather than classical IgE-mediated mechanisms.

Keywords: COVID-19; vaccine; anaphylaxis; antibodies; cytokines

1. Introduction
The United States (US) Food and Drug Administration (FDA) granted emergency
use authorization of the Pfizer BNT162b2 vaccine on 11 December 2020. On 6 January
2021, the US Centers for Disease Control (CDC) announced that there had been 21 cases of
anaphylaxis resulting from the Pfizer BNT162b2 vaccine in the period 14–23 December [1].
In this period, 1,893,360 first doses of the vaccine were administered, with a reaction rate
of 11.1 cases per million doses. Most of the reactions (71%) occurred within 15 min of
vaccination. A total of 17 of the 21 people had a documented history of allergies or allergic
reactions and seven had a history of anaphylaxis.

Singapore’s Health Sciences Authority (HSA) granted interim authorisation for the
Pfizer BNT162b2 vaccine under the Pandemic Special Access Route (PSAR) on 14 December
2020 [2] and the Moderna mRNA-1273 vaccine on 3 February 2021 [3]. As of 18 April
2021, amongst 2,213,888 doses of vaccine administered, there were 20 cases of anaphylaxis
reported with the Pfizer BNT162b2 and Moderna mRNA-1273 vaccines [4]. This is similar
to the incidence rates reported overseas of around 0.5 to 2 per 100,000 doses administered.
Our institution commenced Pfizer BNT162b2 vaccination on 30 December 2020. Within the
first 2 months of vaccine inoculation, there were five cases of anaphylaxis among healthcare
workers in our hospital, with three who consented to our study and fulfilled the Brighton
Collaboration Anaphylaxis Working Group’s case definition [5] (Table 1).

3. Case Presentation and Results
Patient 1, a 42-year-old male, developed flushing, periorbital edema, globus sensation,
and wheezing 30 min after the second dose of the Pfizer BNT162b2 vaccine (Table 1). He
has a history of poorly controlled asthma and urticaria to etoricoxib. He had developed
periorbital edema 3 days after the first dose of the Pfizer BNT162b2 vaccine and assumed
it was an unrelated event. Patient 1 was managed with two doses of intramuscular (IM)
adrenaline and monitored in the high dependency unit. He was hospitalized for 4 days
and received 9 days (2 days intravenous (IV), 7 days oral) of moderate-to-high dose
corticosteriods in total.

Patient 2, a 32-year-old female, developed erythema, flushing, breathlessness, globus
sensation, and wheezing 30 min after the first dose of the Pfizer BNT162b2 vaccine. She
has a history of well controlled asthma and mild, intermittent allergic rhinitis. After the
initial treatment (Table 1), the symptoms recurred at 8 and 27 h post-vaccination, requiring
repeated doses of IM adrenaline. She was hospitalized for 4 days in total and received
regular IV hydrocortisone and diphenhydramine throughout the admission.

Patient 3, a 40-year-old female, developed generalised urticaria, periorbital edema,
globus sensation, and breathlessness 20 min after receiving the second dose of the Pfizer
BNT162b2 vaccine. She has a history of mild, intermittent chronic rhinosinusitis, without
asthma or a history of non-steroidal anti-inflammatory drug hypersensitivity. She reported
numbness of her left forearm 20 min after the first dose of the Pfizer BNT162b2 vaccine
which resolved after 2 days. After initial treatment with IV hydrocortisone and diphenhydramine,
she was discharged after 2 days but returned the same evening complaining of
the recurrence of periorbital edema and globus sensation. She was admitted for another
2 days and required 7 days of moderate-to-high-dose corticosteriods.

4. Discussion
The Pfizer-BioNTech COVID-19 vaccine (BNT162b2) contains modified RNA encoding
the coronavirus spike protein encased by a polymer consisting of (4-hydroxybutyl)azanediyl)-
bis(hexane-6,1-diyl)bis (ALC-3015), (2-hexyldecanoate),2-[(polyethylene glycol)-2000]-N,Nditetradecylacetamide (ALC-0159), 1,2-distearoyl-snglycero-3-phosphocholine (DPSC), and
cholesterol. This vaccine contains several excipients and lipids, and currently PEG-2000 is
one of the excipients with recognised allergenic potential [7]. Clinical immunologists and
allergists have postulated that such reactions could be due to IgE-mediated mechanisms
via anti-PEG IgE or related to pre-existing PEG allergy via anti-PEG IgM or anti-PEG
IgG antibodies resulting in a complement activation-related pseudoallergy (CAPRA) [8,9].
Preexisting anti-PEG IgG/IgM triggers complement activation upon exposure to PEGylated
liposomes, resulting in the generation of anaphylatoxins C3a and C5a which activates
allergic effector cells such as macrophages, basophils, and mast cells [9]. These allergic
effector cells release a variety of inflammatory mediators that cause vascular leakage,
resulting in the clinical presentation of a pseudoallergy. PEGylated lipid nanoparticles
can also directly bind to these allergic effector cells via surface receptors and trigger the
secretory response of these cells [10]. While IgE independent pseudoanaphylaxis has been
demonstrated in animal models, it is still not clearly demonstrable in human pathology [11].
We observe that the clinical course of these three patients is protracted in nature,
lacks hypotension as a feature, has proclivity for symptom recurrence, and requires at
least 4–7 days of moderate-to-high-dose corticosteriods. All patients had elevated C3a
levels which decreased over time, while tryptase levels remained normal, supporting
pseudoallergic reactions as potential mechanisms via a complement activation-related
pseudoallergy (CAPRA). The presence of high IgG to PEG and the Pfizer BNT162b2
vaccine in Patient 2 and high IgG/IgM to PEG and the Pfizer BNT162b2 vaccine in Patient
3, and the lack of IgE antibodies suggest that the reactions could be induced by pre-existing
anti-PEG antibodies. Patient 1’s reaction could be induced directly by the vaccine lipid
nanoparticle activating the complement system, as both antibodies to PEG and the Pfizer
BNT162b2 vaccine are low. Anti-BNT162b2 IgG did not rise in all three patients 4 to 5 weeks
post-anaphylaxis, and we postulate that this might be related to the corticosteroids that
were given as treatment.

Our novel ELISA assay to detect antibodies to the Pfizer BNT162b2 vaccine involves
the coating of the Pfizer BNT162b2 vaccine on ELISA plates to allow the binding of antibodies
in serum samples against all potential immunogenic epitopes of the vaccine. Further
work is required to determine the precise immunogenic epitope of these antibodies directed
against the COVID-19 vaccine, whether it is to the PEG component or pegylated
lipid nanoparticle of the vaccine. The lack of anti-BNT162b2 IgE and trypase response
is intriguing, suggesting a potential mast cell and type 1 hypersensitivity independent
event. This was confirmed by employing two different anti-human IgE antibodies in our
assays (BD Pharmingen (San Diego, CA, USA) and Sigma-Aldrich (Merck KGaA, Germany)),
and additional IgG depletion assays to rule out competitive binding, with all
samples < 2.5 standard deviations of optical density from the blank.
Studies have shown that the prevalence of anti-PEG antibodies in healthy populations
ranges from 20 to 44% [12]. Population studies are required to determine the prevalance of
anti-PEG or anti-BNT162b2 antibodies and to determine a cut-off value that could serve
as a diagnostic test to distinguish the at-risk population who will develop anaphylaxis to
mRNA COVID-19 vaccines.

5. Conclusions
To date, the cause of anaphylaxis post mRNA COVID-19 vaccination remains unclear.
Many authors postulate that PEG could be a potential allergen via IgE- and non-IgEmediated
mechanisms [8–10]. Further studies are required to dissect the immunological
mechanisms of anaphylaxis post COVID-19 mRNA vaccination, with larger cohorts for
the prevalance of anti-PEG and/or anti-BNT162b2 antibodies, and to establish a potential
cut-off value for COVID-19 mRNA vaccine-related anaphylaxis.

References
1. CDC COVID-19 Response Team; Food and Drug Administration. Allergic Reactions Including Anaphylaxis after Receipt of the
First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14–23, 2020. MMWR Morb. Mortal. Wkly. Rep. 2021,
70, 46–51. [CrossRef] [PubMed]
2. Health Sciences Authority, Singapore. Interim Authorisation of Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) for Active Immunisation
to Prevent COVID-19 Disease in Singapore. Available online: https://www.hsa.gov.sg/announcements/dear-healthcareprofessional-
letter/interim-authorisation-of-pfizer-biontech-covid-19-vaccine-(bnt162b2)-for-active-immunisation-toprevent-
covid-19-disease-in-singapore (accessed on 14 December 2020).
3. Health Sciences Authority, Singapore. HSA Grants Interim Authorisation for Moderna COVID-19 Vaccine in Singapore. Available
online: https://www.hsa.gov.sg/announcement...ts-interim-authorisation-for-moderna-covid-19
-vaccine-in-singapore (accessed on 3 February 2021).
4. Health Sciences Authority, Singapore. MicrosoftWord—HSAs Safety Update on the COVID-19 Vaccines (18 April 2021)_Final
(cwp.sg). Available online: https://www-hsa-gov-sg-admin.cwp.sg/docs/default-source/hprg-vcb/safety-update-on-covid1
9-vaccines/safety-update-no-1-on-covid-19-vaccines-(18-apr-2021) (accessed on 10 August 2021).
5. Rüggeberg, J.U.; Gold, M.S.; Bayas, J.M.; Blum, M.D.; Bonhoeffer, J.; Friedlander, S.; de Souza Brito, G.; Heininger, U.; Imoukhuede,
B.; Khamesipour, A.; et al. Brighton Collaboration Anaphylaxis Working Group. Anaphylaxis: Case definition and guidelines for
data collection, analysis, and presentation of immunization safety data. Vaccine 2007, 25, 5675–5684. [CrossRef]
6. Stone, S.F.; Cotterell, C.; Isbister, G.K.; Holdgate, A.; Brown, S.G. Emergency Department Anaphylaxis Investigators. Elevated
serum cytokines during human anaphylaxis: Identification of potential mediators of acute allergic reactions. J. Allergy Clin.
Immunol. 2009, 124, 786–792. [CrossRef] [PubMed]
7. Klimek, L.; Novak, N.; Cabanillas, B.; Jutel, M.; Bousquet, J.; Akdis, C.A. Allergenic components of the mRNA-1273 vaccine
for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation. Allergy 2021.
[CrossRef] [PubMed]
8. Banerji, A.; Wickner, P.G.; Saff, R.; Stone, C.A., Jr.; Robinson, L.B.; Long, A.A.; Wolfson, A.R.; Williams, P.; Khan, D.A.;
Phillips, E.; et al. mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and
Suggested Approach. J. Allergy Clin. Immunol. Pract. 2021, 9, 1423–1437. [CrossRef] [PubMed]
9. Risma, K.A.; Edwards, K.M.; Hummell, D.S.; Little, F.F.; Norton, A.E.; Stallings, A.;Wood, R.A.; Milner, J.D. Potential Mechanisms
of Anaphylaxis to COVID-19 mRNA Vaccines. J. Allergy Clin. Immunol. 2021, 147, 2075–2082. [CrossRef] [PubMed]
10. Mohamed, M.; Abu Lila, A.S.; Shimizu, T.; Alaaeldin, E.; Hussein, A.; Sarhan, H.A.; Szebeni, J.; Ishida, T. PEGylated liposomes:
Immunological responses. Sci. Technol. Adv. Mater. 2019, 20, 710–724. [CrossRef] [PubMed]
11. Finkelman, F.D.; Khodoun, M.V.; Strait, R. Human IgE-independent systemic anaphylaxis. J. Allergy Clin. Immunol. 2016, 137,
1674–1680. [CrossRef] [PubMed]
12. Hong, L.;Wang, Z.;Wei, X.; Shi, J.; Li, C. Antibodies against polyethylene

PDF

 

[Countrymouse]

Buick Electra posted this in the Q thread but I think it deserves a stand alone thread.

This army flight surgeon recommends that "all injected pilots and flight crews are grounded for their risk of cardiac arrest in flight, while carrying personnel or munitions." 3 pulmonary embolisms in ICU within 48 hours of jab at Ft. Hood. It's just horrifying. The bodies of some of our fittest young soldiers just falling apart after taking the vax.

Please take the time to read the whole thing. The beginning may be a bit dry as she is listing all of her many qualifications. I've worked with army flight surgeons. I know how much care is taken to ensure that our military pilots and crews are in top physical condition in order to do their jobs. Just can't believe that this is being swept under the rug and that this doctor has to put her career on the line to get the message out.

I'm not used to posting articles so if someone can bring it over for me I would much appreciate it.

AFFIDAVIT OF LTC. THERESA LONG M.D. IN SUPPORT OF A MOTION FOR A PRELIMINARY INJUNCTION ORDER – Deep Capture

Goosebeans, Buick Electra, or EMICT---

CAN ANY of you find and POST her "ATTACHMENTS" given to this Affadavit / Deposition?

It is THOSE documents that provide the PROOF for what she is saying.

I ESPECIALLY want to see that report of the TOXICITY of one of the vaccine ingredients, since there's a question about that.

Thanks!

 

[Bogey]

God bless her! Another brave soul pulling back the curtain.

 

[psychgirl]

Probably the most damning and educated write up we’ve seen, yet. The woman’s credentials are above and beyond even the most astute physician in the medical community, in my opinion.
I’d enjoy seeing any of our “resident shot defenders” try to tear THIS one apart....

 

[ghost]

Just refuse to take the shot.
Your life depends on it.
You are GODS child, no matter what?

 

[jed turtle]

I'll bet she has a mysterious accident soon.

I’ll bet China will note the debilitation of our pilots and decide that the time to attack us is “soon”...

 

[jed turtle]

True, but I found FAR more concerning and noticeable THIS statement:

I have noted that one of the primary ingredients of the Lipid Nanoparticle delivery system is “ALC 1035” (two attachments, parts highlighted) in the Pfizer shots. The fourth attachment is the toxicity report on ALC-1035, which comprises between 30-50% of the total ingredients. 3 The Safety Data Sheet, (attached as Exhibit B) for this primary ingredient states that it is Category 2 under the OSHA HCS regulations (21 CFR 1910) and includes several concerning warnings, including but not limited to:

1. Seek medical attention if it comes into contact with your skin;
2. If inhaled and If breathing is difficult, give cardiopulmonary resuscitation
3. Evacuate if there is an environmental spill
4. the chemical, physical, and toxicological properties have not been completely investigated
5. Caution: Product has not been fully validated for medical applications. For research use only

25. Other journals and scientific papers also denote that this particular ingredient has never been used in humans before...

Now I WISH this copy of her statement included her ATTACHMENTS_--because "if" this "ALC-1035" IS PEG (Polyethylene Glycol) and IF it is the SAME Polyethylene Glycol used in laxatives--thenWHY would there be a "TOXICITY REPORT" on "ALC-1035" and WHY would this "TOXIC" substance "comprise between 30-50% of the total ingredients"? If "ALC-1035" IS "Polyethylene Glycol" then WHY is it listed as a Category 2 substance under OSHA regulations, necessitating the above warnings?

OBVIOUSLY, "ALC-1035" MUST be something QUITE DIFFERENT from normal "Polyethylene Glycol".

I've been trying to do a search on "ALC 1035"---came up dry, so tried "ALC 1035 Pfizer" and so far have found "some" concerning things---but all of them seem to indicate that ALC-1035" either IS polyethylene glycol, OR---that there's some missing piece to this puzzle I'm not getting yet. The use of PEG in laxatives and the WARNINGS about it which she cites above don't match---

and this is MORE than just her confusing "Polyethylene Glycol" with "Ethylene Glycol"---look again at her statement:

one of the primary ingredients of the Lipid Nanoparticle delivery system is “ALC 1035” (two attachments, parts highlighted) in the Pfizer shots.

AND

The fourth attachment is the toxicity report on ALC-1035,

For further review, I did find ONE tiny study done in Singpore, about anaphylactic reactions to the Polyethylene Glycol in the Pfizer shots. This is a PDF (link below) and I do note it mentions the "1035" figure as being something related to the Immunoglobulin G (IgG) which is (per Wikipedia) "IgG is the main type of antibody found in blood and extracellular fluid, allowing it to control infection of body tissues. By binding many kinds of pathogens such as viruses, bacteria, and fungi, IgG protects the body from infection."

I copied only the Introduction, Description, and Conclusions of the study (it's 7 pages total if you go to the link)

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine
https://www.mdpi.com › pdf

Case Report
Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine:
Report of 3 Cases of Anaphylaxis Post Pfizer
BNT162b2 Vaccination
Xin Rong Lim 1,* , Bernard Pui Leung 1,2, Carol Yee Leng Ng 3, Justina Wei Lynn Tan 1, Grace Yin Lai Chan 1,
Chien Mei Loh 3, Gwendolyn Li Xuan Tan 3, Valerie Hui Hian Goh 3, Lok To Wong 3, Chong Rui Chua 3,
Sze Chin Tan 1, Samuel Shang Ming Lee 1, Hwee Siew Howe 1, Bernard Yu Hor Thong 1 and Khai Pang Leong 1,3


Citation: Lim, X.R.; Leung, B.P.; Ng,
C.Y.L.; Tan, J.W.L.; Chan, G.Y.L.; Loh,
C.M.; Tan, G.L.X.; Goh, V.H.H.; Wong,
L.T.; Chua, C.R.; et al. Pseudo-
Anaphylactic Reactions to Pfizer
BNT162b2 Vaccine: Report of 3 Cases
of Anaphylaxis Post Pfizer BNT162b2
Vaccination. Vaccines 2021, 9, 974.

https://doi.org/10.3390/

vaccines9090974
Academic Editor: Stefano D’Errico
Received: 5 July 2021
Accepted: 27 August 2021
Published: 31 August 2021

Copyright: © 2021 by the authors.

1 Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng,
Singapore 308433, Singapore; bernard.p.leung@gmail.com (B.P.L.); justina_tan@ttsh.com.sg (J.W.L.T.);
grace_yl_chan@ttsh.com.sg (G.Y.L.C.); sze_chin_tan@ttsh.com.sg (S.C.T.);
samuel_lee@ttsh.com.sg (S.S.M.L.); Howe_hwee_siew@ttsh.com.sg (H.S.H.);
bernard_thong@ttsh.com.sg (B.Y.H.T.); khai_pang_leong@ttsh.com.sg (K.P.L.)
2 Health and Social Sciences, Singapore Institute of Technology, Singapore 138683, Singapore
3 Clinical Immunology Laboratory, Tan Tock Seng Hospital, Singapore 308433, Singapore;
carol_ng@ttsh.com.sg (C.Y.L.N.); chien_mei_loh@ttsh.com.sg (C.M.L.);
Gwendolyn_TAN@ttsh.com.sg (G.L.X.T.); Hui_Hian_Valerie_GOH@ttsh.com.sg (V.H.H.G.);
Lok_To_WONG@ttsh.com.sg (L.T.W.); Chong_Rui_CHUA@ttsh.com.sg (C.R.C.)
* Correspondence: xin_rong_lim@ttsh.com.sg; Tel.: +(65)-6357-7822; Fax: +(65)-6357-2686

Abstract: Anaphylactic reactions were observed after Singapore’s national coronavirus disease 2019 (COVID-19) vaccination programme started in December 2020. We report the clinical and laboratory features of three patients in our institution who developed anaphylactic reactions after receiving the Pifzer BNT162b2 vaccine. IgM and IgG antibodies, but not IgE antibodies to the Pfizer BNT162b2 vaccine, were detected in all subjects. Similarly, mild to high elevated levels of anti-polyethylene glycol (PEG) IgG (1035–19709 U/mL, vs. vaccine-naive < 265 U/mL, vaccine-tolerant < 785 U/mL) and IgM (1682–5310 U/mL, vs. vaccine-naive < 1011 U/mL, vaccine-tolerant < 1007 U/mL) were detected in two out of three patients via commercial ELISA. High levels of serum anaphylatoxin C3a
(79.0 6.3 g/mL, mean SD, vs. normal < 10 g/mL) were observed in all three patients during
the acute phase of the reaction, while tryptase levels, a marker of mast cell activation, were not
elevated. Finally, one patient with the highest levels of anti-PEG IgG, IgM, and anti-Pfizer BNT162b2
IgG and IgM exhibited an enhanced Th2 cytokine serum profile during an acute reaction, with high
levels of IL-4 (45.7 pg/mL, vs. vaccine-naive/tolerant < 2.30 pg/mL), IL-33 (86.4 pg/mL, vs. vaccinenaive/
tolerant < 5.51 pg/mL) and IL-10 (22.9 pg/mL, vs. vaccine-naive/tolerant < 12.49 pg/mL)
diminishing over time following corticosteroid treatment. Taken together, we propose these cases
of anaphylaxis described are driven by a complement activation-related pseudoallergy (CAPRA),
rather than classical IgE-mediated mechanisms.

Keywords: COVID-19; vaccine; anaphylaxis; antibodies; cytokines

1. Introduction
The United States (US) Food and Drug Administration (FDA) granted emergency
use authorization of the Pfizer BNT162b2 vaccine on 11 December 2020. On 6 January
2021, the US Centers for Disease Control (CDC) announced that there had been 21 cases of
anaphylaxis resulting from the Pfizer BNT162b2 vaccine in the period 14–23 December [1].
In this period, 1,893,360 first doses of the vaccine were administered, with a reaction rate
of 11.1 cases per million doses. Most of the reactions (71%) occurred within 15 min of
vaccination. A total of 17 of the 21 people had a documented history of allergies or allergic
reactions and seven had a history of anaphylaxis.

Singapore’s Health Sciences Authority (HSA) granted interim authorisation for the
Pfizer BNT162b2 vaccine under the Pandemic Special Access Route (PSAR) on 14 December
2020 [2] and the Moderna mRNA-1273 vaccine on 3 February 2021 [3]. As of 18 April
2021, amongst 2,213,888 doses of vaccine administered, there were 20 cases of anaphylaxis
reported with the Pfizer BNT162b2 and Moderna mRNA-1273 vaccines [4]. This is similar
to the incidence rates reported overseas of around 0.5 to 2 per 100,000 doses administered.
Our institution commenced Pfizer BNT162b2 vaccination on 30 December 2020. Within the
first 2 months of vaccine inoculation, there were five cases of anaphylaxis among healthcare
workers in our hospital, with three who consented to our study and fulfilled the Brighton
Collaboration Anaphylaxis Working Group’s case definition [5] (Table 1).

3. Case Presentation and Results
Patient 1, a 42-year-old male, developed flushing, periorbital edema, globus sensation,
and wheezing 30 min after the second dose of the Pfizer BNT162b2 vaccine (Table 1). He
has a history of poorly controlled asthma and urticaria to etoricoxib. He had developed
periorbital edema 3 days after the first dose of the Pfizer BNT162b2 vaccine and assumed
it was an unrelated event. Patient 1 was managed with two doses of intramuscular (IM)
adrenaline and monitored in the high dependency unit. He was hospitalized for 4 days
and received 9 days (2 days intravenous (IV), 7 days oral) of moderate-to-high dose
corticosteriods in total.

Patient 2, a 32-year-old female, developed erythema, flushing, breathlessness, globus
sensation, and wheezing 30 min after the first dose of the Pfizer BNT162b2 vaccine. She
has a history of well controlled asthma and mild, intermittent allergic rhinitis. After the
initial treatment (Table 1), the symptoms recurred at 8 and 27 h post-vaccination, requiring
repeated doses of IM adrenaline. She was hospitalized for 4 days in total and received
regular IV hydrocortisone and diphenhydramine throughout the admission.

Patient 3, a 40-year-old female, developed generalised urticaria, periorbital edema,
globus sensation, and breathlessness 20 min after receiving the second dose of the Pfizer
BNT162b2 vaccine. She has a history of mild, intermittent chronic rhinosinusitis, without
asthma or a history of non-steroidal anti-inflammatory drug hypersensitivity. She reported
numbness of her left forearm 20 min after the first dose of the Pfizer BNT162b2 vaccine
which resolved after 2 days. After initial treatment with IV hydrocortisone and diphenhydramine,
she was discharged after 2 days but returned the same evening complaining of
the recurrence of periorbital edema and globus sensation. She was admitted for another
2 days and required 7 days of moderate-to-high-dose corticosteriods.

4. Discussion
The Pfizer-BioNTech COVID-19 vaccine (BNT162b2) contains modified RNA encoding
the coronavirus spike protein encased by a polymer consisting of (4-hydroxybutyl)azanediyl)-
bis(hexane-6,1-diyl)bis (ALC-3015), (2-hexyldecanoate),2-[(polyethylene glycol)-2000]-N,Nditetradecylacetamide (ALC-0159), 1,2-distearoyl-snglycero-3-phosphocholine (DPSC), and
cholesterol. This vaccine contains several excipients and lipids, and currently PEG-2000 is
one of the excipients with recognised allergenic potential [7]. Clinical immunologists and
allergists have postulated that such reactions could be due to IgE-mediated mechanisms
via anti-PEG IgE or related to pre-existing PEG allergy via anti-PEG IgM or anti-PEG
IgG antibodies resulting in a complement activation-related pseudoallergy (CAPRA) [8,9].
Preexisting anti-PEG IgG/IgM triggers complement activation upon exposure to PEGylated
liposomes, resulting in the generation of anaphylatoxins C3a and C5a which activates
allergic effector cells such as macrophages, basophils, and mast cells [9]. These allergic
effector cells release a variety of inflammatory mediators that cause vascular leakage,
resulting in the clinical presentation of a pseudoallergy. PEGylated lipid nanoparticles
can also directly bind to these allergic effector cells via surface receptors and trigger the
secretory response of these cells [10]. While IgE independent pseudoanaphylaxis has been
demonstrated in animal models, it is still not clearly demonstrable in human pathology [11].
We observe that the clinical course of these three patients is protracted in nature,
lacks hypotension as a feature, has proclivity for symptom recurrence, and requires at
least 4–7 days of moderate-to-high-dose corticosteriods. All patients had elevated C3a
levels which decreased over time, while tryptase levels remained normal, supporting
pseudoallergic reactions as potential mechanisms via a complement activation-related
pseudoallergy (CAPRA). The presence of high IgG to PEG and the Pfizer BNT162b2
vaccine in Patient 2 and high IgG/IgM to PEG and the Pfizer BNT162b2 vaccine in Patient
3, and the lack of IgE antibodies suggest that the reactions could be induced by pre-existing
anti-PEG antibodies. Patient 1’s reaction could be induced directly by the vaccine lipid
nanoparticle activating the complement system, as both antibodies to PEG and the Pfizer
BNT162b2 vaccine are low. Anti-BNT162b2 IgG did not rise in all three patients 4 to 5 weeks
post-anaphylaxis, and we postulate that this might be related to the corticosteroids that
were given as treatment.

Our novel ELISA assay to detect antibodies to the Pfizer BNT162b2 vaccine involves
the coating of the Pfizer BNT162b2 vaccine on ELISA plates to allow the binding of antibodies
in serum samples against all potential immunogenic epitopes of the vaccine. Further
work is required to determine the precise immunogenic epitope of these antibodies directed
against the COVID-19 vaccine, whether it is to the PEG component or pegylated
lipid nanoparticle of the vaccine. The lack of anti-BNT162b2 IgE and trypase response
is intriguing, suggesting a potential mast cell and type 1 hypersensitivity independent
event. This was confirmed by employing two different anti-human IgE antibodies in our
assays (BD Pharmingen (San Diego, CA, USA) and Sigma-Aldrich (Merck KGaA, Germany)),
and additional IgG depletion assays to rule out competitive binding, with all
samples < 2.5 standard deviations of optical density from the blank.
Studies have shown that the prevalence of anti-PEG antibodies in healthy populations
ranges from 20 to 44% [12]. Population studies are required to determine the prevalance of
anti-PEG or anti-BNT162b2 antibodies and to determine a cut-off value that could serve
as a diagnostic test to distinguish the at-risk population who will develop anaphylaxis to
mRNA COVID-19 vaccines.

5. Conclusions
To date, the cause of anaphylaxis post mRNA COVID-19 vaccination remains unclear.
Many authors postulate that PEG could be a potential allergen via IgE- and non-IgEmediated
mechanisms [8–10]. Further studies are required to dissect the immunological
mechanisms of anaphylaxis post COVID-19 mRNA vaccination, with larger cohorts for
the prevalance of anti-PEG and/or anti-BNT162b2 antibodies, and to establish a potential
cut-off value for COVID-19 mRNA vaccine-related anaphylaxis.

References
1. CDC COVID-19 Response Team; Food and Drug Administration. Allergic Reactions Including Anaphylaxis after Receipt of the
First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14–23, 2020. MMWR Morb. Mortal. Wkly. Rep. 2021,
70, 46–51. [CrossRef] [PubMed]
2. Health Sciences Authority, Singapore. Interim Authorisation of Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) for Active Immunisation
to Prevent COVID-19 Disease in Singapore. Available online: https://www.hsa.gov.sg/announcements/dear-healthcareprofessional-
letter/interim-authorisation-of-pfizer-biontech-covid-19-vaccine-(bnt162b2)-for-active-immunisation-toprevent-
covid-19-disease-in-singapore (accessed on 14 December 2020).
3. Health Sciences Authority, Singapore. HSA Grants Interim Authorisation for Moderna COVID-19 Vaccine in Singapore. Available
online: https://www.hsa.gov.sg/announcement...ts-interim-authorisation-for-moderna-covid-19
-vaccine-in-singapore (accessed on 3 February 2021).
4. Health Sciences Authority, Singapore. MicrosoftWord—HSAs Safety Update on the COVID-19 Vaccines (18 April 2021)_Final
(cwp.sg). Available online: https://www-hsa-gov-sg-admin.cwp.sg/docs/default-source/hprg-vcb/safety-update-on-covid1
9-vaccines/safety-update-no-1-on-covid-19-vaccines-(18-apr-2021) (accessed on 10 August 2021).
5. Rüggeberg, J.U.; Gold, M.S.; Bayas, J.M.; Blum, M.D.; Bonhoeffer, J.; Friedlander, S.; de Souza Brito, G.; Heininger, U.; Imoukhuede,
B.; Khamesipour, A.; et al. Brighton Collaboration Anaphylaxis Working Group. Anaphylaxis: Case definition and guidelines for
data collection, analysis, and presentation of immunization safety data. Vaccine 2007, 25, 5675–5684. [CrossRef]
6. Stone, S.F.; Cotterell, C.; Isbister, G.K.; Holdgate, A.; Brown, S.G. Emergency Department Anaphylaxis Investigators. Elevated
serum cytokines during human anaphylaxis: Identification of potential mediators of acute allergic reactions. J. Allergy Clin.
Immunol. 2009, 124, 786–792. [CrossRef] [PubMed]
7. Klimek, L.; Novak, N.; Cabanillas, B.; Jutel, M.; Bousquet, J.; Akdis, C.A. Allergenic components of the mRNA-1273 vaccine
for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation. Allergy 2021.
[CrossRef] [PubMed]
8. Banerji, A.; Wickner, P.G.; Saff, R.; Stone, C.A., Jr.; Robinson, L.B.; Long, A.A.; Wolfson, A.R.; Williams, P.; Khan, D.A.;
Phillips, E.; et al. mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and
Suggested Approach. J. Allergy Clin. Immunol. Pract. 2021, 9, 1423–1437. [CrossRef] [PubMed]
9. Risma, K.A.; Edwards, K.M.; Hummell, D.S.; Little, F.F.; Norton, A.E.; Stallings, A.;Wood, R.A.; Milner, J.D. Potential Mechanisms
of Anaphylaxis to COVID-19 mRNA Vaccines. J. Allergy Clin. Immunol. 2021, 147, 2075–2082. [CrossRef] [PubMed]
10. Mohamed, M.; Abu Lila, A.S.; Shimizu, T.; Alaaeldin, E.; Hussein, A.; Sarhan, H.A.; Szebeni, J.; Ishida, T. PEGylated liposomes:
Immunological responses. Sci. Technol. Adv. Mater. 2019, 20, 710–724. [CrossRef] [PubMed]
11. Finkelman, F.D.; Khodoun, M.V.; Strait, R. Human IgE-independent systemic anaphylaxis. J. Allergy Clin. Immunol. 2016, 137,
1674–1680. [CrossRef] [PubMed]
12. Hong, L.;Wang, Z.;Wei, X.; Shi, J.; Li, C. Antibodies against polyethylene

PDF

THANKYOU Countrymouse! You are a very good researcher!

 

[Bogey]

"I have noted that one of the primary ingredients of the Lipid Nanoparticle delivery system is “ALC 1035” (two attachments, parts highlighted) in the Pfizer shots. The fourth attachment is the toxicity report on ALC-1035, which comprises between 30-50% of the total ingredients. 3 The Safety Data Sheet, (attached as Exhibit B) for this primary ingredient states that it is Category 2 under the OSHA HCS regulations (21 CFR 1910) and includes several concerning warnings, including but not limited to:"

Is ALC 1035 the actual ingredient or is it ALC 0315? If it's 0315 … strike two and the BS meter is getting close to red lining.

ALC-0315 | Lipid Nanoparticle Component | MedChemExpress

ALC-0315 is an ionisable aminolipid that is responsible for mRNA compaction and aids mRNA cellular delivery and its cytoplasmic release through suspected endosomal destabilization. ALC-0315 can be used to form lipid nanoparticle (LNP) delivery vehicles. Lipid-Nanoparticles have been used in the...

www.medchemexpress.com

ALC-0315
Cat. No.: HY-138170 Purity: ≥98.0% Data Sheet SDS Handling Instructions
ALC-0315 is an ionisable aminolipid that is responsible for mRNA compaction and aids mRNA cellular delivery and its cytoplasmic release through suspected endosomal destabilization. ALC-0315 can be used to form lipid nanoparticle (LNP) delivery vehicles. Lipid-Nanoparticles have been used in the research of mRNA COVID-19 vaccine.
For research use only. We do not sell to patients.

 

[TFergeson]

The CDC and the FDA are civilian agencies that do not have the mission of National Defense that the DOD has. Guidance and recommendations made by these civilian agencies must be filtered through strategic perspective of national defense and the potential risks recommendations may have on the health of the entire fighting force. Ensuring that the health of the fighting force is not compromised is a strategic imperative, for which every military physician is responsible to of the entire fighting force. Ensuring that the health of the fighting force is not compromised is a strategic imperative, for which every military physician is responsible to ensure.

This is my biggest concern. It was the national security implications of the Vaxx that first got me researching

 

[bw]

suspected endosomal destabilization.

Suspected? We THINK we know how this works? So let's inject it in everyone and find out! What could go wrong?

 

[mistaken1]

Another source ......

https://americasfrontlinedoctors.org/legal/colorado-lawsuits/

 

[Walrus]

Probably the most damning and educated write up we’ve seen, yet. The woman’s credentials are above and beyond even the most astute physician in the medical community, in my opinion.
I’d enjoy seeing any of our “resident shot defenders” try to tear THIS one apart....

There'll be a lot said about this doctor and the path she's chosen. For me, it's good that - while vaguely referencing the work of Dr. McCullough, for instance - that she's apparently following military protocols (not that I understand the arena she's playing in) at least initially, but I get the feeling that she knows that line will be dead-ended at some point in the near future if it isn't successfully buried in the mass media. But she will then have the option of going rogue, such as alignment with the FLCCC, et al - if/when her chosen path is closed down.

Kudos to her and prayers for her protection and blessing.

 

[Walrus]

Just refuse to take the shot.
Your life depends on it.
You are GODS child, no matter what?

And while refusing, one's options remain open. Taking the jab is an irreversible decision; after that has happened, the only remaining option is whether or not one chooses to take innumerable "booster" shots.

 

[Publius]

From the looks of it she makes a very good case and to read she is getting threats form people above her in rank.
This is the kind of reports and data I'm looking for, problem is getting her to show up for a court case that I would file and I would need more info/data deaths and injuries from the private sector and lots of it to convince a jury.
The goal is to punish the drug companies and stop the supply of the bogus vaccine.

 

[Profit of Doom]

Probably the most damning and educated write up we’ve seen, yet. The woman’s credentials are above and beyond even the most astute physician in the medical community, in my opinion.
I’d enjoy seeing any of our “resident shot defenders” try to tear THIS one apart....

Hold his beer...